Prof. Daniel (Dani) Cohen
| Professor Daniel (Dani) Cohen is with Tel Aviv University (TAU) since 2002 and has been a full Professor since 2007. Previously, he served in the Israel Defense Force as the Director of the Infectious Diseases Research Institute in the Medical Corps. Prof. Cohen served as the Head of Tel Aviv University School of Public Health and as an elected member of the Executive Committee of Tel Aviv University Senate. He has been the Diana & Stanley Steyer Chair of Cancer Prevention and Control (2009-2024) and the Director of the Stanley Steyer Institute for Cancer Epidemiology and Research (2009-2018). Prof. Cohen is the founder and director of the Summer International Institute of Advanced Epidemiology and Preventive Medicine at TAU School of Public Health (since 2012) and co-founder of the Master of Public Health Program at the School of Medicine, Copperbelt University, Zambia. He has also served as an executive board member and then Chairperson of the Middle East Consortium for Infectious Diseases Surveillance (MECIDS) and acts on various national and international advisory boards in the field of infectious diseases and vaccines. Prof. Cohen has been a consultant for the World Health Organization on several occasions. In November 2020, he was appointed to the WHO Technical Advisory Group on candidate vaccine prioritization (TAG-CVP) and since February 2026 he is also member of the WHO Technical Advisory Group on Shigella Vaccines Prof. Cohen and his research lab at the TAU School of Public Health focus on the development and evaluation of vaccines, with a particular emphasis on Shigella vaccines. He supervised many graduate and post-graduate students, received several research awards and has authored over 300 peer-reviewed articles. In September 2025, he received the Lifetime Achievement Award from the Israel Association of Public Health Physicians for significant contribution to advancing public health in Israel |
